Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 3 5Phase 2 2Phase 1 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Breast Neoplasms 522Leukemia, Myeloid, Acute 498Neoplasms 380Carcinoma, Non-Small-Cell Lung 379Pancreatic Neoplasms 328Precursor Cell Lymphoblastic Leukemia-Lymphoma 318Multiple Myeloma 311Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 288Neoplasm Metastasis 284Brain Neoplasms 275Lymphoma 271Lung Neoplasms 269Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 241Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 161Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

pembrolizumab 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Neoplasm Recurrence, Local × Clear all
NCT06912087 2025-12-02

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

University of Chicago

Phase 1 Recruiting
36 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

NCT00110526 2013-10-24

Gene Therapy for Prostate Cancer That Returns After Radiation Therapy

Icahn School of Medicine at Mount Sinai

Phase 1 Withdrawn
Genitourinary

Neoplasm Recurrence, Local, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡